“EFFICACY OF NIVOLUMAB (NWO) DURING 2+ LINE TREATMENT AND QUALITY OF LIFE IN PATIENTS WITH ADVANCED REFRACTORY NON-SMALL CELL LUNG CANCER: INTERIM RESULTS OF PROSPECTIVE OBSERVATIONAL STUDY”. Voprosy Onkologii, vol. 65, no. 1, Jan. 2019, pp. 99-105, https://doi.org/10.37469/0507-3758-2019-65-1-99-105.